【Event Review】Hiray Pharmaceutical's CPHI China 2026 Shanghai Journey Comes to a Perfect Close

Category：

Company News

From June 16 to 18, 2026, the much-anticipated 24th CPHI China (CPHI China 2026) grandly opened at the Shanghai New International Expo Centre in Pudong, drawing global attention over the three-day event. Throughout this period, the Hiray Pharmaceutical team, with great enthusiasm, presented to domestic and international visitors our full-chain CDMO capabilities for Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates—spanning process R&D, pilot scale-up, and commercial production. We highlighted our advanced manufacturing capabilities for the Orforglipron series of intermediates and APIs, while providing professional and high-quality services.

CPHI China 2026 Highlights

The three-day CPHI & PMEC China 2026 exhibition has now come to a successful conclusion. Throughout this grand event, the Hiray Pharmaceutical booth at E7F02 was bustling with activity, as both new and long-standing clients visited in succession. We shared our latest products, exchanged cutting-edge technologies, and engaged in discussions on new industry developments, creating an exceptionally vibrant atmosphere. Looking back at the exhibition, the lively conversations and the constant flow of attendees still seem to echo, painting a vivid picture of dynamic industry exchange.

To every friend who visited the Hiray Pharmaceutical booth—your attention and recognition are our greatest motivation to move forward. Here, Hiray Pharmaceutical sincerely thanks you for your support and trust. We look forward to reuniting with you in 2027, continuing this world-class, mutually anticipated encounter!